Impact of pathogen inactivation (INTERCEPT Blood System (TM)) on platelet utilization during three years of routine use

Osselaer, Jean-Claude;Doyen, Chantal;Chatelain, Christian;DEBRY, Cécile;Corash, L. M.;et.al.
(2007) 60th Annual Meeting of the American-Association-of-Blood-Banks — Location: Anaheim(Ca) (20.October.2007)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 401.33 KB

Details

Authors
  • Osselaer, Jean-Claude
    Author
  • Doyen, ChantalUCLouvain
    Author
  • Chatelain, Christian
    Author
  • DEBRY, CécileUCLouvain
    Author
  • Bosly, AndréUCLouvain
    Author
  • Corash, L. M.
    Author
Show more
Affiliations

Citations

Osselaer, J.-C., Doyen, C., Chatelain, C., DEBRY, C., Goffaux, M., Messe, N., van Hooydonk, M., Sonet, A., Bosly, A., Lin, J. S., & Corash, L. M. (2007). Impact of pathogen inactivation (INTERCEPT Blood System (TM)) on platelet utilization during three years of routine use. Transfusion, 47(3), 18A-19A. https://doi.org/10.1111/j.1537-2995.2007.01059.x (Original work published 2007)